[HTML][HTML] Impact of T-Cell Engagers on COVID-19–Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy
CM Lee, PG Choe, CK Kang, HJ Jo… - Cancer Research and …, 2024 - ncbi.nlm.nih.gov
Purpose B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
Impact of T-Cell Engagers on COVID-19-Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy
CM Lee, PG Choe, CK Kang, HJ Jo… - Cancer Research …, 2024 - snucm.elsevierpure.com
PURPOSE: B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
Impact of T-Cell Engagers on COVID-19-Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy
CM Lee, PG Choe, CK Kang, HJ Jo… - Cancer research …, 2024 - pubmed.ncbi.nlm.nih.gov
Purpose B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
Impact of T-Cell Engagers on COVID-19-Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy.
CM Lee, PG Choe, CK Kang, HJ Jo, NJ Kim… - Cancer Research and …, 2023 - europepmc.org
Purpose B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
[PDF][PDF] Impact of T-Cell Engagers on COVID-19–Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy
CM Lee, PG Choe, CK Kang, HJ Jo, NJ Kim… - Cancer Res …, 2024 - e-sciencecentral.org
Purpose B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
Impact of T-cell Engagers on COVID-19-related Mortality in B-cell Lymphoma Patients Receiving B-cell Depleting Therapy
CM Lee, PG Choe, CK Kang, HJ Jo, NJ Kim… - Cancer Research and …, 2023 - e-crt.org
Purpose B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the COVID-19 pandemic. We …
for patients with hematologic malignancies, including during the COVID-19 pandemic. We …
[PDF][PDF] Impact of T-Cell Engagers on COVID-19–Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy
CM Lee, PG Choe, CK Kang, HJ Jo, NJ Kim… - Cancer Res …, 2024 - scienceopen.com
Purpose B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
Impact of T-cell Engagers on COVID-19-related Mortality in B-cell Lymphoma Patients Receiving B-cell Depleting Therapy.
CM Lee, PG Choe, CK Kang, HJ Jo, NJ Kim… - Cancer Research and …, 2023 - europepmc.org
Purpose B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the COVID-19 pandemic. We …
for patients with hematologic malignancies, including during the COVID-19 pandemic. We …
[HTML][HTML] Impact of T-Cell Engagers on COVID-19–Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy
CM Lee, PG Choe, CK Kang, HJ Jo, NJ Kim… - Cancer Research and …, 2023 - e-crt.org
Purpose B-cell depleting therapies, including T-cell engager (TCE), are increasingly used
for patients with hematologic malignancies, including during the coronavirus disease 2019 …
for patients with hematologic malignancies, including during the coronavirus disease 2019 …